Research from Sapir Medical Center in the area of proteinuria published

Investigators publish new data in the report "Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats." According to recent research from Kfar Saba, Israel, "Halofuginone is a novel antifibrotic agent that can reverse the fibrotic process by specific inhibition of collagen type I synthesis. To evaluate the effect of Halo on the development of glomerulosclerosis and interstitial fibrosis in the 5/6 nephrectomy rat model Male Wistar rats were assigned to undergo 5/6 NX or sham operation, and then divided into three groups: 5/6 NX rats (NX-Halo and NX-Control) and sham. Systolic blood pressure, proteinuria and body weight were determined every 2 weeks."

...

Want to see the full article?

• Purchase this article for only $3.00